SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurogen (NRGN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (347)6/20/2003 5:38:58 AM
From: Madharry  Read Replies (2) of 523
 
I bought some today. Looks too cheap not to buy.Perhaps this is a more thinly traded stock than I thought. when it dropped into the 4.85 range I put in my market order for 800 more and the price moved some .20 between my first hundred shares and my last hundred shares. I listened to Kostner's presentation of 6/5/03 and I liked it. Seems like there is an awful lot of bang for the buck if they can get a drug approval somewhere along the line. The insomnia and pain management seemed promising to this layperson.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News